| Literature DB >> 26693914 |
Ji-Yeon Shin1, Jeongseon Kim2, Kui Son Choi2,3, Mina Suh3, Boyoung Park2,3, Jae Kwan Jun2,3.
Abstract
PURPOSE: Epidemiological studies have demonstrated an association between excessive salt intake and gastric cancer risk, and this potential risk increases the need for adequate gastric cancer screening in individuals with high salt intake. However, the association between salt intake and gastric cancer screening in the general population has rarely been investigated. We explored the association between salt preference and participation in gastric cancer screening among a nationally representative Korean population.Entities:
Keywords: Dietary sodium; Early detection of cancer; Stomach neoplasms
Mesh:
Substances:
Year: 2015 PMID: 26693914 PMCID: PMC4946365 DOI: 10.4143/crt.2015.333
Source DB: PubMed Journal: Cancer Res Treat ISSN: 1598-2998 Impact factor: 4.679
Study population characteristics, odds ratios, and 95% CI for lifetime gastric cancer screening among pooled 2006-2007 Korea National Cancer Screening Survey (n=3,336)
| Variable | Lifetime gastric cancer screening (weighted %) | cOR (95% CI) | p for trend | aOR[ | p for trend | |
|---|---|---|---|---|---|---|
| No (unweighted n=1,521) | Yes (unweighted n=1,815) | |||||
| Male | 52.4 | 44.9 | 1.00 (reference) | - | 1.00 (reference) | - |
| Female | 47.6 | 55.1 | 1.36 (1.18-1.55) | 1.29 (1.12-1.49) | ||
| 40-49 | 49.8 | 35.7 | 1.00 (reference) | < 0.001 | 1.00 (reference) | < 0.001 |
| 50-59 | 23.9 | 28.5 | 1.66 (1.40-1.97) | 1.71 (1.42-2.05) | ||
| ≥ 60 | 26.3 | 35.8 | 1.90 (1.62-2.24) | 2.02 (1.64-2.49) | ||
| Metropolitan | 49.1 | 45.1 | 1.00 (reference) | 0.003 | 1.00 (reference) | 0.001 |
| Urban | 39.7 | 40.6 | 1.12 (0.96-1.29) | 1.16 (1.00-1.36) | ||
| Rural | 11.2 | 14.3 | 1.39 (1.12-1.73) | 1.44 (1.14-1.81) | ||
| ≤ 1,499 USD | 26.7 | 28.5 | 1.00 (reference) | 0.878 | 1.00 (reference) | < 0.001 |
| 1,500-2,499 USD | 30.2 | 28.1 | 0.87 (0.73-1.05) | 1.25 (1.02-1.53) | ||
| 2,500-3,499 USD | 24.9 | 24.3 | 0.92 (0.76-1.11) | 1.52 (1.21-1.90) | ||
| ≥ 3,500 USD | 18.3 | 19.2 | 0.98 (0.80-1.21) | 1.54 (1.20-1.96) | ||
| ≤ 11 | 36.2 | 45.1 | 1.00 (reference) | < 0.001 | 1.00 (reference) | 0.693 |
| 12-15 | 46.5 | 38.6 | 0.67 (0.57-0.78) | 0.90 (0.74-1.09) | ||
| ≥ 16 | 17.3 | 16.3 | 0.76 (0.62-0.92) | 1.07 (0.84-1.37) | ||
| No | 91.7 | 87.7 | 1.00 (reference) | - | 1.00 (reference) | - |
| Yes | 8.3 | 10.3 | 1.27 (1.01-1.61) | 1.28 (1.00-1.63) | ||
| Good | 66.5 | 55.2 | 1.00 (reference) | < 0.001 | 1.00 (reference) | < 0.001 |
| Fair | 25.3 | 31.2 | 1.48 (1.27-1.73) | 1.49 (1.26-1.74) | ||
| Poor | 8.2 | 13.6 | 2.00 (1.59-2.53) | 1.81 (1.42-2.31) | ||
| Level 1 (very low) | 6.5 | 8.3 | 1.00 (reference) | 0.283 | 1.00 (reference) | 0.052 |
| Level 2 (low) | 35.9 | 36.1 | 0.78 (0.59-1.03) | 0.79 (0.59-1.06) | ||
| Level 3 (moderate) | 29.2 | 26.4 | 0.71 (0.53-0.94) | 0.71 (0.53-0.95) | ||
| Level 4 (high) | 27.2 | 28.3 | 0.81 (0.61-1.08) | 0.75 (0.56-1.01) | ||
| Level 5 (very high) | 1.3 | 0.8 | 0.52 (0.25-1.07) | 0.44 (0.20-0.97) | ||
CI, confidence interval; cOR, crude odds ratio; aOR, adjusted odds ratio.
Adjustments were made for age, sex, residential area, monthly household income, education, family history of cancer, and self-rated health status.
aORs and 95% CI for compliance and noncompliance with gastric cancer screening recommendations compared with never-screening by polytomous logistic regression
| Variable | Noncompliance with the recommendation (> 2 years) (unweighted n=332) | Compliance with the recommendation (within 2 years) (unwweighted n=1,483) | ||
|---|---|---|---|---|
| aOR[ | p for trend | aOR[ | p for trend | |
| Male | 1.00 (reference) | - | 1.00 (reference) | - |
| Female | 1.31 (1.02-1.69) | 1.29 (1.11-1.50) | ||
| 40-49 | 1.00 (reference) | < 0.001 | 1.00 (reference) | < 0.001 |
| 50-59 | 1.85 (1.36-2.53) | 1.68 (1.38-2.03) | ||
| ≥ 60 | 1.87 (1.33-2.63) | 2.06 (1.65-2.56) | ||
| Metropolitan | 1.00 (reference) | 0.071 | 1.00 (reference) | < 0.001 |
| Urban | 1.31 (1.01-1.70) | 1.13 (0.97-1.33) | ||
| Rural | 1.54 (1.05-2.24) | 1.42 (1.11-1.80) | ||
| ≤ 1,499 USD | 1.00 (reference) | 0.199 | 1.00 (reference) | 0.001 |
| 1,500-2,499 USD | 1.28 (0.91-1.79) | 1.25 (1.01-1.54) | ||
| 2,500-3,499 USD | 1.43 (0.98-2.09) | 1.54 (1.22-1.95) | ||
| ≥ 3,500 USD | 1.45 (0.97-2.17) | 1.56 (1.20-2.01) | ||
| ≤ 11 | 1.00 (reference) | 0.460 | 1.00 (reference) | 0.601 |
| 12-15 | 0.92 (0.67-1.25) | 0.89 (0.73-1.09) | ||
| ≥ 16 | 0.93 (0.62-1.40) | 1.10 (0.85-1.43) | ||
| No | 1.00 (reference) | - | 1.00 (reference) | - |
| Yes | 1.15 (0.75-1.76) | 1.31 (1.02-1.69) | ||
| Good | 1.00 (reference) | < 0.001 | 1.00 (reference) | < 0.001 |
| Fair | 1.49 (1.13-1.96) | 1.49 (1.26-1.76) | ||
| Poor | 2.50 (1.74-3.59) | 1.66 (1.29-2.15) | ||
| Level 1 (very low) | 1.00 (reference) | 0.681 | 1.00 (reference) | 0.048 |
| Level 2 (low) | 0.66 (0.42-1.05) | 0.82 (0.61-1.12) | ||
| Level 3 (moderate) | 0.60 (0.37-0.98) | 0.74 (0.54-1.00) | ||
| Level 4 (high) | 0.68 (0.42-1.10) | 0.77 (0.56-1.05) | ||
| Level 5 (very high) | 0.68 (0.23-1.99) | 0.38 (0.16-0.92) | ||
aOR, adjusted odds ratio; CI, confidence intervals.
Adjustments were made for age, sex, residential area, monthly household income, education, family history of cancer, and self-rated health status.
aORs and 95% CI for undergoing gastric cancer screening with upper gastrointestinal series and with upper endoscopy compared with never-screening by polytomous logistic regression
| Variable | Upper gastrointestinal series (unweighted n=355) | Upper endoscopy (unweighted n =1,460) | ||
|---|---|---|---|---|
| aOR[ | p for trend | aOR[ | p for trend | |
| Male | 1.00 (reference) | - | 1.00 (reference) | - |
| Female | 1.30 (1.02-1.66) | 1.29 (1.11-1.50) | ||
| 40-49 | 1.00 (reference) | < 0.001 | 1.00 (reference) | < 0.001 |
| 50-59 | 1.49 (1.08-2.04) | 1.76 (1.45-2.13) | ||
| ≥ 60 | 1.86 (1.33-2.61) | 2.06 (1.65-2.56) | ||
| Metropolitan | 1.00 (reference) | < 0.001 | 1.00 (reference) | 0.008 |
| Urban | 1.20 (0.92-1.56) | 1.16 (0.99-1.36) | ||
| Rural | 2.28 (1.63-3.18) | 1.24 (0.96-1.58) | ||
| ≤ 1,499 USD | 1.00 (reference) | 0.867 | 1.00 (reference) | < 0.001 |
| 1,500-2,499 USD | 1.16 (0.84-1.60) | 1.28 (1.04-1.59) | ||
| 2,500-3,499 USD | 1.00 (0.68-1.47) | 1.68 (1.32-2.12) | ||
| ≥ 3,500 USD | 1.06 (0.71-1.59) | 1.68 (1.30-2.18) | ||
| ≤ 11 | 1.00 (reference) | 0.742 | 1.00 (reference) | 0.879 |
| 12-15 | 0.74 (0.54-1.01) | 0.94 (0.77-1.15) | ||
| ≥ 16 | 1.05 (0.71-1.56) | 1.08 (0.83-1.40) | ||
| No | 1.00 (reference) | - | 1.00 (reference) | - |
| Yes | 1.22 (0.81-1.85) | 1.29 (1.00-1.67) | ||
| Good | 1.00 (reference) | 0.574 | 1.00 (reference) | < 0.001 |
| Fair | 1.27 (0.97-1.67) | 1.54 (1.30-1.82) | ||
| Poor | 1.32 (0.89-1.96) | 1.95 (1.52-2.52) | ||
| Level 1 (very low) | 1.00 (reference) | 0.121 | 1.00 (reference) | 0.125 |
| Level 2 (low) | 0.56 (0.36-0.86) | 0.87 (0.64-1.19) | ||
| Level 3 (moderate) | 0.53 (0.34-0.82) | 0.77 (0.56-1.06) | ||
| Level 4 (high) | 0.58 (0.37-0.90) | 0.81 (0.59-1.12) | ||
| Level 5 (very high) | 0.32 (0.09-1.21) | 0.49 (0.21-1.12) | ||
aOR, adjusted odds ratio; CI, confidence interval.
Adjustments were made for age, sex, residential area, monthly household income, education, family history of cancer, and self-rated health status.